What is the share price of Fabino Enterprises Ltd (FABINO) today?
The share price of FABINO as on 27th April 2026 is ₹20.31. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Fabino Enterprises Ltd (FABINO) share?
The past returns of Fabino Enterprises Ltd (FABINO) share are- Past 1 week: 4.96%
- Past 1 month: 51.57%
- Past 3 months: N/A%
- Past 6 months: -24.78%
- Past 1 year: -21.73%
- Past 3 years: -26.94%
- Past 5 years: -49.67%
What are the peers or stocks similar to Fabino Enterprises Ltd (FABINO)?
The peers or stocks similar to Fabino Enterprises Ltd (FABINO) include:What is the market cap of Fabino Enterprises Ltd (FABINO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fabino Enterprises Ltd (FABINO) is ₹4.27 Cr as of 27th April 2026.What is the 52 week high and low of Fabino Enterprises Ltd (FABINO) share?
The 52-week high of Fabino Enterprises Ltd (FABINO) is ₹27 and the 52-week low is ₹13.01.What is the PE and PB ratio of Fabino Enterprises Ltd (FABINO) stock?
The P/E (price-to-earnings) ratio of Fabino Enterprises Ltd (FABINO) is -7.62. The P/B (price-to-book) ratio is 1.17.Which sector does Fabino Enterprises Ltd (FABINO) belong to?
Fabino Enterprises Ltd (FABINO) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Fabino Enterprises Ltd (FABINO) shares?
You can directly buy Fabino Enterprises Ltd (FABINO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Fabino Enterprises Ltd
FABINO Share Price
BSE₹20.310.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
SIP
FABINO Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
AvgAverage profitability - not good, not bad
Entry point
BadThe stock is in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
FABINO Performance & Key Metrics
FABINO Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 1.17 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.15 | 5.91 | 0.49% |
FABINO Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
FABINO Company Profile
Fabino Enterprises Ltd is a pharmaceutical company in India offering a wide range of allopathic, herbal, and Covid-19 products, including food supplements and veterinary products.
PE Ratio
35.16
35.16
1Y Return
8.49%
8.49%
Buy Reco %
93.55
93.55
TORNTPHARM
PE Ratio
81.40
81.40
1Y Return
32.55%
32.55%
Buy Reco %
85.19
85.19
LAURUSLABS
PE Ratio
142.62
142.62
1Y Return
139.44%
139.44%
Buy Reco %
61.54
61.54
ZYDUSLIFE
PE Ratio
21.68
21.68
1Y Return
27.36%
27.36%
Buy Reco %
57.69
57.69
PE Ratio
27.12
27.12
1Y Return
13.34%
13.34%
Buy Reco %
67.74
67.74
FABINO Forecast
FABINO Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
FABINO
FABINO
Income
Balance Sheet
Cash Flow
Quarterly Normal View
FABINO Income Statement
FABINO Income Statement
Quarterly Normal View
| Quarter | jun 2021 | sep 2021 | ||
|---|---|---|---|---|
| Total Revenue | 1.13 | 0.93 | ||
Operating & Other expenses | 1.10 | 1.00 | ||
EBITDA | 0.03 | -0.07 | ||
| Depreciation/Amortization | 0.01 | -0.01 | ||
| PBIT | 0.02 | -0.06 | ||
| Interest & Other Items | 0.00 | 0.00 | ||
| PBT | 0.02 | -0.06 | ||
| Taxes & Other Items | 0.01 | -0.01 | ||
| Net Income | 0.01 | -0.05 | ||
| EPS | 0.11 | 0.00 |
FABINO Company Updates
FABINO Stock Peers
FABINO Past Performance & Peer Comparison
FABINO Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Fabino Enterprises Ltd | -7.62 | 1.17 | — |
| Sun Pharmaceutical Industries Limited | 35.16 | 5.23 | 0.87% |
| Torrent Pharmaceuticals Ltd | 81.40 | 10.19 | 0.72% |
| Laurus Labs Ltd | 142.62 | 23.34 | 0.09% |
Compare valuation on ScreenerFABINO Stock Price Comparison
Compare FABINO with any stock or ETFCompare FABINO with any stock or ETF
FABINO
FABINO Holdings
FABINO Shareholdings
FABINO Promoter Holdings Trend
FABINO Promoter Holdings Trend
FABINO Institutional Holdings Trend
FABINO Institutional Holdings Trend
No institutional holdings trend are available
FABINO Shareholding Pattern
FABINO Shareholding Pattern
FABINO Shareholding History
FABINO Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing FABINO stock
smallcases containing FABINO stock
Looks like this stock is not in any smallcase yet.
FABINO Events
FABINO Events
FABINO Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
FABINO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
FABINO Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
FABINO has not given any dividends in last 5 years
FABINO Dividends
FABINO Dividends
Hmm, looks like data is unavailable here. Please come back after some timeFABINO Stock News & Opinions
FABINO Stock News & Opinions
Articles & Videos
Corporate
Corporate
Fabino Enterprises Limited to review financial results at board meeting November 11Fabino Enterprises Limited will hold a board meeting on Wednesday, November 11, 2026, to consider and approve the unaudited standalone financial results for the half year ended September 30, 2026, along with a limited review report, according to a regulatory filing. The trading window for the company will reopen 48 hours after the financial results are declared to the stock exchanges.
18 hours agoCapital Market - Live
Corporate
Corporate
Fabino Enterprises Limited reported no rematerialisation requests to BSE for the September quarterFabino Enterprises Limited, formerly known as Fabino life sciences limited, has submitted a certificate to the BSE Limited under Regulation 74(5) of the SEBI (Depositories and Participants Regulations) 2018, for the quarter ended September 30th, 2026, confirming that the company did not receive any requests for rematerialisation or dematerialisation during that period, as certified by Cameo Corporate Services Limited, the Registrar and Share Transfer Agent (RTA), and Bigshare Services Pvt. Ltd.
2 weeks agoCapital Market - Live
Corporate
Corporate
Fabino Enterprises Limited will rebrand to Raavi Greenz Resources Limited, pending approvalsFabino Enterprises Limited will change its name to Raavi Greenz Resources Limited, subject to shareholder approval and regulatory clearances, according to a corporate disclosure filed with the BSE Limited on Monday, October 12, 2026. The board also approved alterations to the company’s Memorandum of Association to reflect its focus on biofuel, renewable resources, and related agro-based businesses, and to enable the company to undertake new business activities.
3 weeks agoCapital Market - Live
Corporate
Corporate
Fabino Enterprises Limited adds three directors to its board, effective TuesdayFabino Enterprises Limited announced the appointment of three additional directors to its board on Tuesday, September 29, 2026. Mr. Samrat Vardhan Dutta was appointed as a Non-Executive Director, Mr. Sarthak Goyal as an Executive Director in the Promoter category, and Mr. Rahul Mangla as an Independent Director, all with terms until the conclusion of the company's ensuing Annual General Meeting.
1 month agoCapital Market - Live
Corporate
Corporate
Fabino Enterprises Limited adds three directors to its board, effective TuesdayFabino Enterprises Limited announced the appointment of three additional directors to its board on Tuesday, September 29, 2026. Mr. Samrat Vardhan Dutta was appointed as a Non-Executive Director, Mr. Sarthak Goyal as an Executive Director in the Promoter category, and Mr. Rahul Mangla as an Independent Director, all with terms until the conclusion of the company's ensuing Annual General Meeting.
1 month agoCapital Market - Live
Corporate
Corporate
Fabino Enterprises Limited halts trading for insiders pending financial results announcementFabino Enterprises Limited, formerly known as Fabino life sciences limited, will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the announcement of the company’s unaudited financial results for the half year ended September 30, 2026, in accordance with SEBI regulations.
1 month agoCapital Market - Live
Corporate
Corporate
Fabino Enterprises Limited closes its register for an AGM on September 29, 2026Fabino Enterprises Limited, formerly known as Fabino Life Sciences Limited, will close its Register of Members and Share Transfer Books from September 22, 2026, to September 28, 2026, for its 15th Annual General Meeting to be held on September 29, 2026, via video conference or other audio-visual means.
2 months agoCapital Market - Live
Corporate
Corporate
Fabino Enterprises schedules board meetingFabino Enterprises will hold a meeting of the Board of Directors of the Company on 23 May 2026.
5 months agoCapital Market - Live
Corporate
Corporate
Fabino Enterprises to declare Quarterly ResultsFabino Enterprises will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
11 months agoCapital Market - Live
Corporate
Corporate
Fabino Enterprises schedules AGMFabino Enterprises announced that the 14th Annual General Meeting(AGM) of the company will be held on 22 September 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant